1. Search Result

Search Result

Targets Recommended: CRISPR/Cas9

Results for "1628752-83-9" in MCE Product Catalog:

Cat. No. Product Name Target Research Area
  • HY-50767S
    Palbociclib D8

    PD 0332991 D8

    CDK Cancer
    Palbociclib D8 (PD 0332991 D8) is a deuterium labeled Palbociclib. Palbociclib is a selective and orally active CDK4 and CDK6 inhibitor with IC50s of 11 and 16 nM, respectively. Palbociclib has no activity against other protein kinases. Palbociclib has potently anticancer activities.